Regulation of T cell function by NK cell receptors for classical MHC class I molecules

Current Opinion in Immunology

Volumn 12, Issue 3, 2000, Pages 295-300

  Ugolini, Sophie ^a   Vivier, Eric ^a  

^a CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; CELL RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

HUMAN; IMMUNOREGULATION; LYMPHOCYTE FUNCTION; MEMORY CELL; MOUSE; NATURAL KILLER CELL; NONHUMAN; REVIEW; T LYMPHOCYTE;

EID: 0034008510     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(00)00090-X     Document Type: Review

References (67)

1. Long E.O. Regulation of immune responses through inhibitory receptors. Annu Rev Immunol. 17:1999;875-904.
2. Daëron M., Vivier E. Biology of immunoreceptor tyrosine-based inhibition motif bearing molecules. Curr Top Microbiol Immunol. 244:1999;1-12.
3. Yokoyama W.M. Natural killer cell receptors. Curr Opin Immunol. 10:1998;298-305.
4. Moretta A., Bottino C., Millo R., Biassoni R. HLA-specific and non-HLA-specific human NK receptors. Curr Top Microbiol Immunol. 244:1999;69-84.
5. Colonna M., Lopez-Botet M., Navarro F. A novel family of inhibitory receptors for HLA class I molecules that modulate function of lymphoid and myeloid cells. Curr Top Microbiol Immunol. 244:1999;115-122.
6. Cosman D., Fanger N., Borges L. Human cytomegalovirus, MHC class I and inhibitory signalling receptors: more questions than answers. Immunol Rev. 168:1999;177-185.
7. Biassoni R., Cantoni C., Falco M., Verdiani S., Bottino C., Vitale M., Conte R., Poggi A., Moretta A., Moretta L. The human leukocyte antigen (HLA)-C-specific 'activatory' or 'inhibitory' natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions. J Exp Med. 183:1996;645-650.
8. Olcese L., Cambiaggi A., Semenzato G., Bottino C., Moretta A., Vivier E. Killer-cell activatory receptors for MHC class I molecules are included in a multimeric complex expressed by human killer cells. J Immunol. 158:1997;5083-5086.
9. Vivier E., Daëron M. Immunoreceptor tyrosine-based inhibition motifs (ITIMs). Immunol Today. 18:1997;286-291.
10. Burshtyn D.N., Long E.O. Regulation through inhibitory receptors: lessons from natural killer cells. Trends Cell Biol. 7:1997;473-479.
11. Tomasello E., Olcese L., Vely F., Geourgeon C., Blery M., Moqrich A., Gautheret D., Djabali M., Mattei M.G., Vivier E. Gene structure, expression pattern, and biological activity of mouse killer cell activating receptor-associated protein (KARAP)/DAP-12. J Biol Chem. 273:1998;34115-34119.
12. Lanier L.L., Corliss B.C., Wu J., Leong C., Phillips J.H. Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells. Nature. 391:1998;703-707.
13. Lanier L.L., Corliss B., Wu J., Phillips J.H. Association of DAP-12 with activating CD94/NKG2C NK cell receptors. Immunity. 8:1998;693-701.
14. Campbell K.S., Cella M., Carretero M., Lopez-Botet M., Colonna M. Signaling through human killer cell activating receptors triggers tyrosine phosphorylation of an associated protein complex. Eur J Immunol. 28:1998;599-609.
15. Nakajima H., Samaridis J., Angman L., Colonna M. Human myeloid cells express an activating ILT receptor (ILT1) that associates with Fc receptor gamma-chain. J Immunol. 162:1999;5-8.
16. Campbell K.S., Colonna M. DAP12: a key accessory protein for relaying signals by natural killer cell receptors. Int J Biochem Cell Biol. 31:1999;631-636.
17. b heavy chains. Eur J Immunol. 28:1998;370-378.
18. Garrido F., Ruiz-Cabello F., Cabrera T., Pérez-Villar J.J., Lỳpez-Botet M., Duggan-Keen M., Stern P.L. Implications for immunosurveillance of altered HLA class I phenotypes in human tumors. Immunol Today. 18:1997;89-95.
19. Tay C.H., Szomolanyi-Tsuda E., Welsh R.M. Control of infections by NK cells. Curr Top Microbiol Immunol. 230:1998;193-220.
20. Mingari M.C., Ponte M., Cantoni C., Vitale C., Schiavetti F., Bertone S., Bellomo R., Tradori-Cappai A., Biassoni R. HLA-class I-specific inhibitory receptors in human cytolytic T lymphocytes: molecular characterization, distribution in lymphoid tissues and co-expression by individual T cells. Int Immunol. 9:1997;485-491.
21. Colonna M., Navarro F., Bellon T., Liano M., Garcia P., Samaridis J., Angman L., Cella M., Lopez-Botet M. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J Exp Med. 186:1997;1809-1818.
22. Coles M.C., McMahon C.W., Takisawa H., Raulet D.H. Memory CD8 T lymphocytes express inhibitory MHC-specific Ly49 receptors. Eur J Immunol. 30:2000;236-244. This report extensively characterises for the first time the Ly49+CD8+ memory-phenotype T cells.
23. Torkar M., Norgate Z., Colonna M., Trowsdale J., Wilson M.J. Isotypic variation of novel immunoglobulin-like transcript/killer cell inhibitory receptor loci in the leukocyte receptor complex. Eur J Immunol. 28:1998;3959-3967.
24. Wende H., Colonna M., Ziegler A., Volz A. Organization of the leukocyte receptor cluster (LRC) on human chromosome 19q13.4. Mamm Genome. 10:1999;154-160.
25. Valiante N.M., Uhrberg M., Shilling H.G., Lienert-Weidenbach K., Arnett K.L., D'Andrea A., Phillips J.H., Lanier L.L., Parham P. Functionally and structurally distinct NK cell receptor repertories in the peripheral blood of two human donors. Immunity. 7:1997;739-751.
26. Mingari M.C., Moretta A., Moretta L. Regulation of KIR expression in human T cells: a safety mechanism that may impair protective T-cell responses. Immunol Today. 19:1998;153-157.
27. Yu H., Fehniger T.A., Fuchshuber P., Thiel K.S., Vivier E., Carson W.E., Caligiuri M.A. Flt3 ligand promotes the generation of a distinct CD34+ human natural killer cell progenitor that responds to interleukin-15. Blood. 92:1998;3647-3657.
28. + T cells is controlled by T-cell receptor engagement. Nature. 403:2000;325-328.
29. •], this article shows that cytokines (TGF-β or IL-15) induce the expression of CD94-NKG2A in antigen-stimulated T cells in vitro, suggesting that the combination of cytokine- and TCR-stimulation is mandatory for NKR expression.
30. •].
31. •]).
32. Chapman T.L., Heikema A.P., Bjorkman P.J. The inhibitory receptor LIR-1 uses a common binding interaction to recognize class I MHC molecules and the viral homolog UL18. Immunity. 11:1999;603-613. Surface plasmon resonance is used for the first dissection of LIR-1 interaction with UL-19, MHC class Ia and MHC class Ib molecules.
33. Fan Q.R., Mosyak L., Garboczi D.N., Winter C.C., Wagtmann N., Long E.O., Wiley D.C. Structure of a human natural killer cell inhibitory receptor. Transplant Proc. 31:1999;1871-1872. An up-to-date review on the X-ray analysis of KIR structure.
34. •] on KIR2DL1.
35. ••].
36. Mingari M.C., Schiavetti F., Ponte M., Vitale C., Maggi E., Romagnani S., Demarest J., Pantaleo G., Fauci A.S., Moretta L. Human CD8+ T lymphocyte subsets that express HLA class I-specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations. Proc Natl Acad Sci USA. 93:1996;12433-12438.
37. Ferrini S., Cambiaggi A., Meazza R., Sforzini S., Marciano S., Mingari M.C., Moretta L. T cell clones expressing the natural killer cell-related p58 receptor molecule display heterogeneity in phenotypic properties and p58 function. Eur J Immunol. 24:1994;2294-2298.
38. Mingari M.C., Vitale C., Cambiaggi A., Schiavetti F., Melioli G., Ferrini S., Poggi A. Cytolytic T lymphocytes displaying natural killer (NK)-like activity: expression of NK-related functional receptors for HLA class I molecules (p58 and CD94) and inhibitory effect on the TCR-mediated target cell lysis or lymphokine production. Int Immunol. 7:1995;697-703.
39. Phillips J.H., Gumperz J.E., Parham P., Lanier L.L. Superantigen-dependent, cell-mediated cytotoxicity inhibited by MHC class I receptors on T lymphocytes. Science. 268:1995;403-405.
40. Halary F., Peyrat M-A., Champagne E., Lopez-Botet M., Moretta A., Moretta L., Vié H., Fournié J-J., Bonneville M. Control of self-reactive cytotoxic T lymphocytes expressing γδ T cell receptors by natural killer inhibitory receptors. Eur J Immunol. 27:1997;2812-2821.
41. Battistini L., Borsellino G., Sawicki G., Poccia F., Salvetti M., Ristori G., Brosnan C.F. Phenotypic and cytokine analysis of human peripheral blood gamma delta T cells expressing NK cell receptors. J Immunol. 159:1997;3723-3730.
42. Bakker A.B., Phillips J.H., Figdor C.G., Lanier L.L. Killer cell inhibitory receptors for MHC class I molecules regulate lysis of melanoma cells mediated by NK cells, gamma delta T cells, and antigen-specific CTL. J Immunol. 160:1998;5239-5245.
43. D'Andrea A., Chang C., Phillips J.H., Lanier L.L. Regulation of T cell lymphokine production by killer cell inhibitory receptor recognition of self HLA class I alleles. J Exp Med. 184:1996;789-794.
44. Ikeda H., Lethé B., Lehmann F., Van Baren N., Baurain J-F., De Smet C., Chambost H., Vitale M., Moretta A., Boon T., Coulie P.G. Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor. Immunity. 6:1997;199-208.
45. Cambiaggi A., Darche S., Guia S., Kourilski P., Abastado J.P., Vivier E. Modulation of T cell functions in KIR2DL3 (CD158b) transgenic mice. Blood. 94:1999;1-8. This is the first report using KIR transgenic mice, which indicates that the function of KIRs on T cells might be more complex than a mere extinction of T cell effector function.
46. Marti F., Xu C.W., Selvakumar A., Brent R., Dupont B., King P.D. LCK-phosphorylated human killer cell-inhibitory receptors recruit and activate phosphatidylinositol 3-kinase. Proc Natl Acad Sci USA. 95:1998;11810-11815. The authors show that KIRs can bind p85 PI 3-kinase via ITIMs and thereby activate PI 3-kinase and Akt.
47. Takei F., Brennan J., Mager D.L. The Ly-49 family: genes, proteins and recognition of class I MHC. Immunol Rev. 155:1997;67-77.
48. McQueen K.L., Freeman J.D., Takei F., Mager D.L. Localization of five new Ly49 genes, including three closely related to Ly49c. Immunogenetics. 48:1998;174-183.
49. Salcedo M., Diehl A.D., Olsson-Alheim M.Y., Sundbäck J., Van Kaer L., Kärre K., Ljunggren H.G. Altered expression of Ly49 Inhibitory receptors on natural killer cells from MHC class I-deficient mice. J Immunol. 158:1997;3174-3180.
50. Held W., Raulet D.H. Ly49A transgenic mice provide evidence for a major histocompatibility complex-dependent education process in natural killer cell development. J Exp Med. 185:1997;2079-2088.
51. Gumperz J.E., Valiante N.M., Parham P., Lanier L.L., Tyan D. Heterogeneous phenotypes of expression of the NKB1 natural killer cell class I receptor among individuals of different human histocompatibility leukocyte antigens types appear genetically regulated, but not linked to major histocompatibility complex haplotype. J Exp Med. 183:1996;1817-1827.
52. Zimmer J., Donato L., Hanau D., Cazenave J.P., Tongio M.M., Moretta A., Salle H. Activity and phenotype of natural killer cells in peptide transporter (TAP)-deficient patients (type I bare lymphocyte syndrome). J Exp Med. 187:1998;117-122. This article and [51] provide the first evidence that the quality and/or the quantity of MHC class I molecules expressed on autologous cells does not influence the expression of KIRs on NK cells.
53. + cells. J Immunol. 160:1998;1158-1165.
54. Ortaldo J.R., Winkler-Pickett R., Willette-Brown J., Wange R.L., Anderson S.K., Palumbo G.J., Mason L.H., McVicar D.W. Structure/function relationship of activating Ly-49D and inhibitory Ly-49G2 NK receptors. J Immunol. 163:1999;5269-5277.
55. Held W., Raulet D.H. Expression of the Ly49A gene in murine natural killer cell clones is predominantly but not exclusively mono-allelic. Eur J Immunol. 27:1997;2876-2884.
56. Held W., Kunz B., Lowin-Kropf B., van de Wetering M., Clevers H. Clonal acquisition of the Ly49A NK cell receptor is dependent on the trans-acting factor TCF-1. Immunity. 11:1999;433-442. The first evidence that Ly49A is controlled by the transcription factor TCF-1.
57. Williams N.S., Klem J., Puzanov I.J., Sivakumar P.V., Bennett M., Kumar V. Differentiation of NK1.1+, Ly49+ NK cells from Flt3+ multipotent marrow progenitor cells. J Immunol. 163:1999;2648-2656.
58. d as well as the kinetic constants of this interaction.
59. ••].
60. •], this article reports the first analysis of the specificities of Ly49 molecules using soluble MHC class I tetramers.
61. •].
62. Chiu Y.H., Jayawardena J., Weiss A., Lee D., Park S.H., Dautry-Varsat A., Bendelac A. Distinct subsets of CD1d-restricted T cells recognize self-antigens loaded in different cellular compartments. J Exp Med. 189:1999;103-110.
63. Zajac A.J., Vance R.E., Held W., Sourdive D.J., Altman J.D., Raulet D.H., Ahmed R. Impaired anti-viral T cell responses due to expression of the Ly49A inhibitory receptor. J Immunol. 163:1999;5526-5534.
64. Pauza M., Smith K.M., Neal H., Reilly C., Lanier L.L. Transgenic expression of Ly-49A in thymocytes alters repertoire selection. J Immunol. 164:2000;884-892.
65. Fahlen L., Öberg L., Brännström T., Khoo N.K.S., Lendahl U., Sentman C.L. Ly49A expression on T cells alters T cell selection. Int Immunol. 12:2000;215-222.
66. Falco M., Biassoni R., Bottino C., Vitale M., Sivori S., Augugliaro R., Moretta L., Moretta A. Identification and molecular cloning of p75/AIRM1, a novel member of the sialoadhesin family that functions as an inhibitory receptor in human natural killer cells. J Exp Med. 190:1999;793-802.
67. Cantoni C., Bottino C., Augugliaro R., Morelli L., Marcenaro E., Castriconi R., Vitale M., Pende D., Sivori S., Millo R.et al. Molecular and functional characterization of IRp60, a member of the immunoglobulin superfamily that functions as an inhibitory receptor in human NK cells. Eur J Immunol. 29:1999;3148-3159.